Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III multicenter randomized double-blind crossover consistency study of a urea-[13C] breath test kit versus Helicobacter Test INFAI for diagnosis of Helicobacter pylori infection
CTR20251855Phase 3Active
- Sponsor
- 辐瑞森生物科技
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 13C urea, urea in Helicobacter pylori infection, sponsored by 辐瑞森生物科技. Started May 2025; status: active.
02
Drugs
13C ureaurea
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on CTR20251855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251855.